Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in patients with Amyotrophic Lateral Sclerosis Ruchika Sharma11 Sept 2024 12:30 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical study of NLRP3...
Ravulizumab lacks treatment effect, highlights unmet need for highly effective treatment for ALS Medha Baranwal18 Nov 2023 9:30 AM ISTUSA: A recent study published in JAMA Neurology investigated the safety and efficacy of ravulizumab, a complement C5 inhibitor, in adults with...
Medical Bulletin 19/August/2023 Isra Zaman19 Aug 2023 3:30 PM ISTHere are the top medical news of the day:Walkable communities are healthier for both mom and baby: StudyPregnant women that live in walkable...
Novel insights into protein-mediated motor neuron loss in amyotrophic lateral sclerosis Isra Zaman19 Aug 2023 9:30 AM ISTIn patients with ALS, the motor dysfunction symptoms usually appear in one part of the body, such as the limbs, and then progress to others. This...
Doctor highlights need for patient registry for rare diseases Sanchari Chattopadhyay27 Jun 2023 3:30 PM ISTBengaluru: While attending the 2nd international conference on ALS/MND (Amyotrophic lateral sclerosis/Motor neuron disease), Dr Harsha...
Medical Bulletin 10/February/2023 Isra Zaman10 Feb 2023 3:15 PM ISTHere are the top medical news for the day:International study finds calorie restriction to slow pace of aging in healthy adultsAn international team...
Study examines large-scale generation of muscle-controlling nerve cells from ALS patients Isra Zaman10 Feb 2023 9:30 AM ISTA new Cedars-Sinai study in collaboration with the University of California, Irvine (UCI) and the Answer ALS consortium published in the peer-reviewed...
FDA approves Relyvrio as new treatment option for ALS Dr. Kamal Kant Kohli3 Oct 2022 11:30 AM ISTThe Food and Drug Administration (FDA) has granted approval to a new treatment option in form of Relyvrio (sodium phenylbutyrate and taurursodiol) for...
Medical Bulletin 1/October/2022 Isra Zaman1 Oct 2022 2:38 PM ISTHere are the top medical news for the day:Another possible monkey virus spillover threat for humansAn obscure family of viruses, already endemic in...
New marker of ALS outcome identified Isra Zaman1 Oct 2022 10:00 AM ISTA study by Human Brain Project (HBP) researchers has identified a new marker for predicting the clinical outcome of patients with Amyotrophic Lateral...
CPS Mumbai notifies on Counselling Process for Basic, Advanced Life Support courses, Details Debmitra Das2 Jun 2022 9:30 AM ISTMumbai: Advanced Life Support (ALS) and Basic Life Support (BLS) courses counselling process have been scheduled for registered students of DCH &...
IIT Hyderabad Researchers find New Molecule to potentially treat ALS Medical Dialogues Bureau6 Feb 2020 3:28 PM ISTALS is a neurodegenerative disorder that severely affects the voluntary movement of the muscles and can lead to paralysis and death & occurs due to...
